Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;201(2):183-184.
doi: 10.1111/bjh.18769. Epub 2023 Mar 27.

The continuing global challenges of treating patients with beta-thalassemia

Ariel Koren  1
Affiliations

The continuing global challenges of treating patients with beta-thalassemia

Ariel Koren. Br J Haematol. 2023 Apr.

Abstract

In this issue, Hokland et al. offer an interesting view of the different approaches on how to treat a beta-thalassemia patient. The principal concerns, that this report reveals, are the very wide differences in the facilities and economic resources available for the care of patients. Management of thalassemia should become a word wide health care priority and may include at last those two steps: national and international registries; national programs for screening couples at risk and providing preventive measures to prevent births of patients with thalassemia. Commentary on: Hokland et al. Thalassaemia-A global view. Br J Haematol. 2023;201:208-223.

Keywords: hemoglobinopathies; immigrant family; β thalassemia patients.

PubMed Disclaimer

References

REFERENCES

    1. Hokland P, Daar S, Khair W, Sheth S, Taher AT, Torti L, et al. Thalassaemia-A global view. Br J Haematol. 2023;201(2):208-223.
    1. Capellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion dependent thalassaemia (TDT). 3rd ed. Nicosia, Cyprus: Thalassaemia International Federation; 2014.
    1. Koren A, Profeta L, Zalman L, Palmor H, Levin C, Zamir RB, et al. Prevention of β thalassemia in northern Israel-a cost-benefit analysis. Mediterr J Hematol Infect Dis. 2014;6(1):e2014012.
    1. Farmakis D, Angastiniotis M, El Ghoul MM, Cannon L, Eleftheriou A. Thalassaemia registries: a call for action. A position statement from the Thalassaemia International Federation. Hemoglobin. 2022;46(4):225-32.
    1. Sivalingam J, SuE Y, Lim ZR, Lam ATL, Lee AP, Lim HL, et al. A scalable suspension platform for generating high-density cultures of universal red blood cells from human induced pluripotent stem cells. Stem Cell Rep. 2021;16(1):182-97.

LinkOut - more resources